Cruse Michael
SEC CIK 1854179 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| OKUR | OnKure Therapeutics, Inc. | Senior VP-Corp. Ops | 13.7K | $67.3K | — | 5 | 2021-08-25 | 2022-09-01 |
Most active insiders at OKUR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Leverone Jason A. | CFO | — | $4,379 |
| 2 | Saccomano Nicholas A | Pres, CEO, Dir | — | $1,253 |
| 3 | Manke Isaac | Dir | — | — |
| 4 | Mathers Edward T | Dir | — | — |
Cruse Michael made no open-market trades at OKUR in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-09-02 | 2022-09-01 | OKUR | OnKure Therapeutics, Inc. | Cruse Michael | COO | P - Purchase | $3.39 | +7,500 | 13.7K | +121% | +$25.4K |
| M | 2022-08-31 | 2022-08-29+ | OKUR | OnKure Therapeutics, Inc. | Cruse Michael | COO | P - Purchase | $3.17 | +1,058 | 31.8K | +3% | +$3,350 |
| MI | 2022-08-31 | 2022-08-29+ | OKUR | OnKure Therapeutics, Inc. | Cruse Michael | COO | P - Purchase | $3.21 | +6,197 | 6,197 | New | +$19.9K |
| D | 2021-12-14 | 2021-12-10 | OKUR | OnKure Therapeutics, Inc. | Cruse Michael | Senior VP-Corp. Ops | A - Grant | $0.00 | +25.0K | 29.1K | +610% | $0 |
| 2021-08-26 | 2021-08-25 | OKUR | OnKure Therapeutics, Inc. | Cruse Michael | Senior VP-Corp. Ops | P - Purchase | $7.45 | +2,500 | 2,500 | New | +$18.6K |
Purchase Sale Sale after option exercise All abbreviations